Home›Companies›Biotech & Pharma›3852.ai

3852.ai Inc

Develops drug combinations for people with hard-to-treat diseases using AI and robotics.

Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About 3852.ai

3852.ai is a private company based in South Burlington, Vermont. It has reported $435,000 raised in one offering on Form D since August 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 13, 2022Aug 13, 2026$435,000fully sold9$48,333Options, Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 3852.ai's Form D filed Aug 13, 2026.

Sources

  1. SEC3852.ai Inc filing history